LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.38	35.02	44.23	100.33	90.87	15.82
Short-Term Investments	29.79	41.56	51.34	32.54	42.33	-
Cash & Short-Term Investments	56.17	76.58	95.57	132.87	133.2	15.82
Cash Growth	-35.29%	-19.88%	-28.07%	-0.25%	742.10%	115.56%
Accounts Receivable	-	-	-	3.25	0.36	1.14
Other Receivables	-	-	-	-	0.37	0.34
Receivables	-	-	-	3.25	0.73	1.48
Prepaid Expenses	1.92	1.07	1.63	4.41	2.57	0.12
Other Current Assets	2.4	1.65	1.7	-	-	0.81
Total Current Assets	60.5	79.3	98.9	140.53	136.51	18.22
Property, Plant & Equipment	0.04	1.44	2.46	2.08	1.95	1.5
Other Long-Term Assets	0.01	0.09	0.32	0.81	0.8	0.77
Total Assets	60.55	80.83	101.67	143.43	139.25	20.49
Accounts Payable	1.43	2.72	4.45	3.97	2.55	0.93
Accrued Expenses	4.18	9.13	4.29	7.83	1.57	1.27
Current Portion of Long-Term Debt	-	4.89	5.28	4.64	-	-
Current Portion of Leases	-	0.32	0.42	0.38	0.26	0.21
Current Unearned Revenue	-	-	-	-	1.53	4.52
Other Current Liabilities	-	0.95	0.46	5.14	5.34	0.41
Total Current Liabilities	5.61	18.01	14.89	21.95	11.25	7.34
Long-Term Debt	-	-	-	-	4.28	3.6
Long-Term Leases	-	0.08	0.42	0.43	0.32	0.27
Long-Term Unearned Revenue	35	35	35	35	-	1.66
Other Long-Term Liabilities	-	-	-	-	5.03	-
Total Liabilities	40.61	53.09	50.31	57.39	20.88	12.87
Common Stock	3.72	3.72	3.72	3.72	3.65	-
Additional Paid-In Capital	212.64	211.66	208.41	194.42	192.27	41.09
Retained Earnings	-187.09	-174.97	-149.86	-108.07	-76.16	-33.39
Comprehensive Income & Other	-9.33	-12.66	-10.9	-4.03	-1.39	-0.08
Shareholders' Equity	19.94	27.75	51.36	86.04	118.37	7.62
Total Liabilities & Equity	60.55	80.83	101.67	143.43	139.25	20.49
Total Debt	-	5.28	6.11	5.45	4.87	4.08
Net Cash (Debt)	56.17	71.3	89.46	127.42	128.34	11.74
Net Cash Growth	-30.34%	-20.30%	-29.79%	-0.72%	993.54%	110.59%
Net Cash Per Share	2.09	2.66	3.35	4.92	6.50	29.40
Filing Date Shares Outstanding	26.31	26.31	26.29	26.29	25.78	0.4
Total Common Shares Outstanding	26.31	26.31	26.29	26.29	25.78	0.4
Working Capital	54.88	61.29	84	118.58	125.26	10.89
Book Value Per Share	0.76	1.05	1.95	3.27	4.59	19.09
Tangible Book Value	19.94	27.75	51.36	86.04	118.37	7.62
Tangible Book Value Per Share	0.76	1.05	1.95	3.27	4.59	19.09
Buildings	-	-	-	0.12	0.12	0.11
Machinery	-	2.65	2.96	2.42	1.95	1.34
Leasehold Improvements	-	0.36	0.38	-	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q